Stock News

$0.23 EPS Expected for Ciena (CIEN); Her Majesty The Queen In Right Of The Province Of Alberta Alberta Investment Management Raised Regeneron Pharmaceuticals (REGN) Stake By $450,000

Ciena Corporation (NYSE:CIEN) Logo

Her Majesty The Queen In Right Of The Province Of Alberta Alberta Investment Management Corp increased Regeneron Pharmaceuticals (REGN) stake by 3.09% reported in 2017Q4 SEC filing. Her Majesty The Queen In Right Of The Province Of Alberta Alberta Investment Management Corp acquired 1,200 shares as Regeneron Pharmaceuticals (REGN)’s stock declined 13.59%. The Her Majesty The Queen In Right Of The Province Of Alberta Alberta Investment Management Corp holds 40,000 shares with $15.04 million value, up from 38,800 last quarter. Regeneron Pharmaceuticals now has $31.96B valuation. The stock decreased 1.73% or $5.21 during the last trading session, reaching $296.6. About 642,571 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has declined 14.19% since May 22, 2017 and is downtrending. It has underperformed by 25.74% the S&P500.

Analysts expect Ciena Corporation (NYSE:CIEN) to report $0.23 EPS on May, 31 before the open.They anticipate $0.15 EPS change or 39.47% from last quarter’s $0.38 EPS. CIEN’s profit would be $33.02M giving it 26.86 P/E if the $0.23 EPS is correct. After having $0.07 EPS previously, Ciena Corporation’s analysts see 228.57% EPS growth. The stock decreased 2.33% or $0.59 during the last trading session, reaching $24.71. About 3.96M shares traded or 16.51% up from the average. Ciena Corporation (NYSE:CIEN) has risen 9.21% since May 22, 2017 and is uptrending. It has underperformed by 2.34% the S&P500.

Since December 14, 2017, it had 0 insider buys, and 52 sales for $4.11 million activity. 2,923 Ciena Corporation (NYSE:CIEN) shares with value of $76,742 were sold by HAMILTON RICK. FRODSHAM JAMES sold 4,000 shares worth $92,564. Rothenstein David M sold $53,907 worth of stock. GALLAGHER PATRICK sold $81,000 worth of stock or 3,000 shares. MOYLAN JAMES E JR sold $52,110 worth of Ciena Corporation (NYSE:CIEN) on Wednesday, May 2. Shares for $22,740 were sold by McFeely Scott. $185,810 worth of Ciena Corporation (NYSE:CIEN) shares were sold by SMITH GARY B.

Among 25 analysts covering Ciena (NYSE:CIEN), 21 have Buy rating, 0 Sell and 4 Hold. Therefore 84% are positive. Ciena had 90 analyst reports since August 18, 2015 according to SRatingsIntel. The rating was maintained by William Blair with “Buy” on Sunday, August 27. The rating was maintained by Northland Capital on Monday, March 19 with “Buy”. Jefferies maintained Ciena Corporation (NYSE:CIEN) on Thursday, June 1 with “Buy” rating. The stock of Ciena Corporation (NYSE:CIEN) has “Buy” rating given on Thursday, December 7 by BMO Capital Markets. Stifel Nicolaus maintained it with “Buy” rating and $28.0 target in Thursday, December 7 report. The stock of Ciena Corporation (NYSE:CIEN) has “Buy” rating given on Friday, June 2 by William Blair. The stock has “Buy” rating by William Blair on Friday, December 8. The rating was maintained by Jefferies on Monday, August 21 with “Buy”. The rating was downgraded by Bank of America on Friday, March 3 to “Neutral”. The rating was maintained by Deutsche Bank on Friday, June 3 with “Hold”.

Another recent and important Ciena Corporation (NYSE:CIEN) news was published by Profitconfidential.com which published an article titled: “Why a Major Breakout Is on the Horizon for Ciena Stock” on April 27, 2018.

Ciena Corporation provides hardware, software, and services that support the transport, switching, aggregation, service delivery, and management of voice, video, and data traffic on communications networks worldwide. The company has market cap of $3.55 billion. The company's Networking Platforms segment offers hardware networking solutions optimized for the convergence of coherent optical transport, optical transport network switching, and packet switching. It has a 5.26 P/E ratio. The Company’s products include 6500 Packet-Optical Platform and the 5430 Reconfigurable Switching System, Waveserver stackable interconnect system, CoreDirector Multiservice Optical Switches, and OTN configuration for the 5410 Reconfigurable Switching System, as well as Z-Series Packet-Optical Platform; 3000 family of service delivery switches and service aggregation switches, and the 5000 family of service aggregation switches, as well as 8700 Packetwave Platform and the Ethernet packet configuration for the 5410 Service Aggregation Switch; and 4200 Advanced Services Platform, 5100/5200 Advanced Services Platform, Common Photonic Layer, and 6100 Multiservice Optical Platform.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.06, from 1 in 2017Q3. It turned negative, as 47 investors sold Ciena Corporation shares while 80 reduced holdings. 44 funds opened positions while 76 raised stakes. 142.49 million shares or 3.75% less from 148.04 million shares in 2017Q3 were reported. 97,378 are held by Bnp Paribas Arbitrage. Fincl Mgmt Professionals accumulated 1,000 shares or 0.01% of the stock. Guggenheim Cap Llc reported 0.03% in Ciena Corporation (NYSE:CIEN). Southport Mgmt Ltd Liability stated it has 30,000 shares. Panagora Asset Mngmt has invested 0% in Ciena Corporation (NYSE:CIEN). Meeder Asset Management Inc has 0.01% invested in Ciena Corporation (NYSE:CIEN). 4.95M are owned by Neuberger Berman Ltd Liability Com. Creative Planning holds 24,587 shares. Shelton Cap Mngmt, a California-based fund reported 11,260 shares. Glenmede Tru Na stated it has 15,794 shares. Ahl Llp invested in 0.02% or 56,784 shares. Hutchin Hill Ltd Partnership reported 118,600 shares. Quentec Asset Llc holds 280,000 shares or 0.92% of its portfolio. Smithfield Trust owns 0% invested in Ciena Corporation (NYSE:CIEN) for 496 shares. Moreover, Stevens Cap Lp has 0.01% invested in Ciena Corporation (NYSE:CIEN) for 16,309 shares.

Her Majesty The Queen In Right Of The Province Of Alberta Alberta Investment Management Corp decreased Scansource Inc (NASDAQ:SCSC) stake by 30,800 shares to 33,500 valued at $1.20M in 2017Q4. It also reduced Firstservice Corp stake by 7,100 shares and now owns 131,638 shares. First Amern Finl Corp (NYSE:FAF) was reduced too.

More notable recent Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) news were published by: Seekingalpha.com which released: “Regeneron Unknown: Eylea Future Competition Effects” on May 17, 2018, also Streetinsider.com with their article: “Regeneron (REGN) Says NEJM Published Two Positive Phase 3 Trials Showing DUPIXENT Improved Moderate-to …” published on May 21, 2018, Seekingalpha.com published: “Regeneron: Initiating At These Levels” on May 10, 2018. More interesting news about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) were released by: Seekingalpha.com and their article: “Why Regeneron Has 30 Percent Upside” published on May 07, 2018 as well as Benzinga.com‘s news article titled: “Regeneron Pharmaceuticals: Sequencing Its Way to +30% Upside” with publication date: May 03, 2018.

Since February 9, 2018, it had 0 buys, and 4 insider sales for $7.43 million activity. 1,000 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares with value of $325,600 were sold by GOLDSTEIN JOSEPH L. 20,000 shares valued at $5.72M were sold by SING GEORGE L on Wednesday, May 9.

Investors sentiment is 1.17 in 2017 Q4. Its the same as in 2017Q3. It has no change, as 62 investors sold REGN shares while 161 reduced holdings. only 71 funds opened positions while 191 raised stakes. 69.17 million shares or 6.15% less from 73.70 million shares in 2017Q3 were reported. First Personal Financial Svcs holds 0% or 45 shares in its portfolio. Of Vermont invested 0% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Baystate Wealth Mngmt Limited Co accumulated 7 shares. Private Advisor Group Incorporated Lc has invested 0.05% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Price T Rowe Associate Md invested 0.04% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Mitsubishi Ufj Securities Co holds 0.25% or 160 shares. Moreover, Asset Management has 0.09% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Thompson Siegel & Walmsley stated it has 0% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Jane Street Group Ltd Com holds 14,515 shares or 0.02% of its portfolio. Parkside Bank And Tru reported 26 shares. Quantbot Technologies Limited Partnership has invested 0.13% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Brown Advisory Inc accumulated 2,835 shares. Moreover, Lazard Asset Mngmt Ltd Liability Com has 0% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Solaris Asset Ltd Liability Corp accumulated 125 shares or 0.03% of the stock. Martingale Asset Management Limited Partnership holds 0% or 603 shares.

Among 33 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 11 have Buy rating, 1 Sell and 21 Hold. Therefore 33% are positive. Regeneron Pharmaceuticals Inc. had 126 analyst reports since July 28, 2015 according to SRatingsIntel. Bernstein maintained the shares of REGN in report on Wednesday, August 5 with “Outperform” rating. BMO Capital Markets maintained it with “Hold” rating and $491.0 target in Monday, September 11 report. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) earned “Outperform” rating by RBC Capital Markets on Wednesday, August 5. The rating was maintained by BMO Capital Markets on Friday, May 4 with “Market Perform”. Leerink Swann maintained the stock with “Outperform” rating in Friday, February 9 report. The rating was initiated by Leerink Swann on Friday, February 5 with “Outperform”. As per Thursday, August 3, the company rating was upgraded by Credit Suisse. The stock has “Buy” rating by Brean Capital on Tuesday, March 8. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has “Hold” rating given on Thursday, February 8 by BMO Capital Markets. Roth Capital upgraded Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday, January 19 to “Buy” rating.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *